AnatomyOrganismsDiseasesChemicals and DrugsAnalytical, Diagnostic and Therapeutic Techniques and EquipmentPsychiatry and PsychologyPhenomena and ProcessesDisciplines and OccupationsAnthropology, Education, Sociology and Social PhenomenaTechnology, Industry, AgricultureInformation ScienceNamed GroupsHealth CareGeographicals
AspirinCardiovascular DiseasesRisk FactorsPlatelet Aggregation InhibitorsAnti-Inflammatory Agents, Non-SteroidalHypertensionCohort StudiesProspective StudiesAtherosclerosisRisk AssessmentBiological MarkersFollow-Up StudiesBlood PressureMetabolic Syndrome XObesityDiabetes Mellitus, Type 2StrokeIncidenceCross-Sectional StudiesTiclopidinePrimary PreventionPrevalenceProportional Hazards ModelsDiabetes MellitusPlatelet AggregationThromboxane B2C-Reactive ProteinCoronary DiseaseDyslipidemiasMyocardial InfarctionBody Mass IndexUnited StatesRiskCyclooxygenase InhibitorsSex FactorsTime FactorsCholesterolSmokingLipidsAge FactorsLife StyleCause of DeathPlatelet Function TestsDiabetic AngiopathiesHomocysteineInflammationDiabetes ComplicationsCholesterol, LDLDrug Therapy, CombinationCholesterol, HDLSalicylatesDietBlood PlateletsCoronary Artery DiseaseTreatment OutcomeEndothelium, VascularHydroxymethylglutaryl-CoA Reductase InhibitorsCardiovascular SystemDouble-Blind MethodHyperlipidemiasTriglyceridesHypercholesterolemiaCardiovascular AgentsKidney Failure, ChronicHypolipidemic AgentsMultivariate AnalysisCase-Control StudiesJapanBlood GlucosePredictive Value of TestsDose-Response Relationship, DrugOdds RatioThrombosisComorbidityVascular DiseasesRandomized Controlled Trials as TopicFibrinolytic AgentsCerebrovascular DisordersArteriosclerosisAntihypertensive AgentsMortalitySex DistributionRisk Reduction BehaviorCarotid ArteriesOxidative StressEuropean Continental Ancestry GroupCarotid Intima-Media ThicknessPlatelet ActivationLongitudinal StudiesInsulin ResistanceCalcinosisQuestionnairesAnticoagulantsSodium SalicylateRegression AnalysisChronic DiseaseExerciseLogistic ModelsAntioxidantsHemorrhage